Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag updated to v3.5.4, replacing the prior v3.5.3 tag to indicate a newer release of the page template or documentation.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a new website release of the study details page without altering the study information shown.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This appears to be a metadata/site version change with no visible impact on the study details.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag updated to v3.4.3 and the previous v3.4.2 entry was removed.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.2 was added and older notices including the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.